Bicara Therapeutics Inc..
BCAX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Bicara Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel, dual-action biologics that combine the precision of targeted therapeutics with the power of immunotherapy. Their bifunctional antibodies are designed to simultaneously bind to tumor cells and immune cell...Show More
Better Health for All
0
No specific data or relevant information regarding BCAX.US's performance against the 'Better Health for All' ethical value was found in the provided articles.
1
The articles are clinical trial registrations and do not contain company-specific data on health impact, safety, accessibility, innovation, or other related metrics.
2
Fair Money & Economic Opportunity
0
Bicara Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel biologics.
1
Its core business does not involve lending, insuring, moving, or storing money, nor does it offer financial products or services to consumers. Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable to the company's operations, as per the rubric's definition for a score of 0.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for Bicara Therapeutics Inc. regarding any of the Fair Pay & Worker Respect KPIs. While executive compensation details and the existence of a 401(k) plan with company matching were mentioned, there was no quantitative evidence for metrics such as living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or the percentage of the workforce covered by health insurance.
1
Fair Trade & Ethical Sourcing
0
No evidence available to assess Bicara Therapeutics Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, quantitative evidence was found in the provided articles to assess Bicara Therapeutics Inc. against any of the 'Honest & Fair Business' KPIs. The articles either listed SEC filings without providing their content or offered a general corporate governance overview without specific, measurable data points relevant to the rubric.
1
Kind to Animals
0
No evidence available to assess Bicara Therapeutics Inc. on Kind to Animals.
No War, No Weapons
0
No evidence available to assess Bicara Therapeutics Inc. on No War, No Weapons.
Planet-Friendly Business
0
No specific, concrete data points related to planet-friendly business metrics for Bicara Therapeutics Inc. (BCAX.US) were found in the provided articles.
1
The articles primarily offer general industry analysis and explicitly state that sustainability data for BCAX.US is unavailable.
2
Respect for Cultures & Communities
0
No evidence available to assess Bicara Therapeutics Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Bicara Therapeutics Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No information regarding Bicara Therapeutics Inc.'s waste diversion rate, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs was found in the provided articles.
1
The articles are primarily financial reports and a proxy statement, which explicitly state they do not contain sustainability or environmental data.
2